Smoking Doubles Risk Of Dementia And Alzheimer's Disease
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Smoking Doubles Risk Of Dementia And Alzheimer's Disease

LONDON, ENGLAND -- June 19, 1998 -- Cigarette smokers are more than twice as likely to develop Alzheimer's disease than are non-smokers, according to a large study in this week's issue of The Lancet. Smokers are also more likely to develop vascular dementia-another common form of dementia caused by vascular disease and strokes.

Dr. A. Ott and colleagues from The Netherlands followed up 6,870 men and women, aged 55 years and older, living in a Rotterdam suburb. At the start of the study, none of the men or women had dementia.

They were asked about their smoking habits and classified as never smokers, former smokers, or current smokers. They were then followed up for an average of two years. Any participants who developed signs of possible dementia during the study underwent neuropsychological assessment and, if possible, a brain scan to find out if they had Alzheimer's disease or vascular dementia.

In the study 146 individuals developed dementia during the study, of whom 105 were diagnosed as having Alzheimer's disease.

Current smokers were more than twice as likely to develop dementia of any kind and Alzheimer's disease compared with never smokers. Smokers also tended to develop dementia at a younger age. However, Dr. Ott and colleagues found that smokers who carry the gene for a protein that has been linked to Alzheimer's disease -- APOE epsilon 4 -- are no more likely to develop the disease than are non-smokers. But those who do not carry the gene are more than four times more likely to develop the disease. Why APOE epsilon 4 might protect smokers is not clear.

One explanation, say the researchers, might be that smoking alters brain chemistry in a way that counters some effects of Alzheimer's disease. Another is that smokers with APOE epsilon 4 might die young and do not live long enough to develop the disease.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities